Xolair Patient Portal

Xolair® (omalizumab) This site contains information for UK healthcare professionals only on Xolair and chronic spontaneous urticaria. Xolair is indicated as add-on therapy for the treatment of chronic spontaneous urticaria in adult and adolescent (12 years and above) patients with inadequate response to H1-antihistamine treatment.1.

Any eligible patients who do not have any claims activity for 3 years or more will be removed from the program. For more information, please call the Help Desk at (855) 965-2472. The information contained in this section of the site is intended for US healthcare professionals and specialty pharmacy representatives only. Click “OK” if you are a health care professional or specialty …

There are no warnings about Xolair administration in patients with a history of cancer. In cases such as the one you describe, it is important to have a conversation with the patient about what is and is not known about Xolair and malignancy, to discuss the rationale for its use in this setting, and to monitor the patient closely. Such a discussion will help the patient decide whether or …

Xolair is indicated as add-on therapy to improve asthma control in patients with severe persistent allergic asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and who have reduced lung function (FEV 1 <80%) as well as frequent daytime symptoms or night-time awakenings and who have had multiple documented severe asthma exacerbations …

Xolair wurde in fünf Hauptstudien an über 2 000 Patienten ab 12 Jahren mit allergischem Asthma untersucht, darunter eine Studie an 482 Patienten mit schwerem allergischem Asthma, das mit herkömmlichen Behandlungen nicht ausreichend unter Kontrolle gebracht werden konnte. Darüber hinaus wurde es an 627 Kindern im Alter zwischen sechs und 12 Jahren untersucht.

XOLAIR is given in 1 or more injections under the skin (subcutaneous), 1 time every 2 or 4 weeks. In people with asthma and nasal polyps, a blood test for a substance called IgE must be performed before starting XOLAIR to determine the appropriate dose and dosing frequency. In people with chronic hives, a blood test is not necessary to …

Committed to helping patients access the XOLAIR they have been prescribed. Enroll Now. Submit our forms online or by text for faster and easier enrollment. Patient Assistance Tool. Find the right assistance option for your patients . Coverage. Help understanding benefits and coverage, such as benefits investigations and prior authorization resources . Learn More > …

Xolair Injektionslösung ist eine klare bis leicht opalisierende, farblose bis schwach bräunlich-gelbe Injektionslösung in einer Fertigspritze. Xolair 75 mg Injektionslösung steht als Packung mit 1 Fertigspritze und als Mehrfachpackungen mit 4 ( 4 x 1) oder 10 ( 10 x 1) Fertigspritzen zur Verfügung. Es müssen nicht alle Packungsgrößen in …